Cutaneous Vasculopathy as an Adverse Effect of the Anti–Vascular Endothelial Growth Factor Agent Axitinib
Shi VJ, Galan A, Odell ID, Choi JN. Cutaneous Vasculopathy as an Adverse Effect of the Anti–Vascular Endothelial Growth Factor Agent Axitinib. JAMA Dermatology 2016, 152: 222. PMID: 26509864, DOI: 10.1001/jamadermatol.2015.3209.Peer-Reviewed Original ResearchMeSH KeywordsAxitinibHumansImidazolesIndazolesMaleMiddle AgedProtein Kinase InhibitorsSkin Diseases, VascularVascular Endothelial Growth Factor A